Cargando…
Posibilidad de sesgo en estudio retrospectivo de ivermectina para COVID-19
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SEPAR. Published by Elsevier España, S.L.U.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687363/ https://www.ncbi.nlm.nih.gov/pubmed/34629658 http://dx.doi.org/10.1016/j.arbres.2020.11.004 |
| _version_ | 1783613500848865280 |
|---|---|
| author | Meneses, Giovanni Ortega-Guillén, Eduardo |
| author_facet | Meneses, Giovanni Ortega-Guillén, Eduardo |
| author_sort | Meneses, Giovanni |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7687363 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | SEPAR. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76873632020-11-25 Posibilidad de sesgo en estudio retrospectivo de ivermectina para COVID-19 Meneses, Giovanni Ortega-Guillén, Eduardo Arch Bronconeumol Carta al Director SEPAR. Published by Elsevier España, S.L.U. 2021-04 2020-11-25 /pmc/articles/PMC7687363/ /pubmed/34629658 http://dx.doi.org/10.1016/j.arbres.2020.11.004 Text en © 2020 SEPAR. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Carta al Director Meneses, Giovanni Ortega-Guillén, Eduardo Posibilidad de sesgo en estudio retrospectivo de ivermectina para COVID-19 |
| title | Posibilidad de sesgo en estudio retrospectivo de ivermectina para COVID-19 |
| title_full | Posibilidad de sesgo en estudio retrospectivo de ivermectina para COVID-19 |
| title_fullStr | Posibilidad de sesgo en estudio retrospectivo de ivermectina para COVID-19 |
| title_full_unstemmed | Posibilidad de sesgo en estudio retrospectivo de ivermectina para COVID-19 |
| title_short | Posibilidad de sesgo en estudio retrospectivo de ivermectina para COVID-19 |
| title_sort | posibilidad de sesgo en estudio retrospectivo de ivermectina para covid-19 |
| topic | Carta al Director |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687363/ https://www.ncbi.nlm.nih.gov/pubmed/34629658 http://dx.doi.org/10.1016/j.arbres.2020.11.004 |
| work_keys_str_mv | AT menesesgiovanni posibilidaddesesgoenestudioretrospectivodeivermectinaparacovid19 AT ortegaguilleneduardo posibilidaddesesgoenestudioretrospectivodeivermectinaparacovid19 |